144 related articles for article (PubMed ID: 22690683)
1. Identifying multiple-target ligands via computational chemogenomics approaches.
Peng S; Lin X; Guo Z; Huang N
Curr Top Med Chem; 2012; 12(12):1363-75. PubMed ID: 22690683
[TBL] [Abstract][Full Text] [Related]
2. A chemogenomics view on protein-ligand spaces.
Strömbergsson H; Kleywegt GJ
BMC Bioinformatics; 2009 Jun; 10 Suppl 6(Suppl 6):S13. PubMed ID: 19534738
[TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
4. Drug design of GPCR ligands using physicogenetics and chemogenomics--principles and case studies.
Frimurer TM; Högberg T
Curr Top Med Chem; 2011; 11(15):1882-901. PubMed ID: 21470174
[TBL] [Abstract][Full Text] [Related]
5. In Silico Chemogenomics Drug Repositioning Strategies for Neglected Tropical Diseases.
Andrade CH; Neves BJ; Melo-Filho CC; Rodrigues J; Silva DC; Braga RC; Cravo PVL
Curr Med Chem; 2019; 26(23):4355-4379. PubMed ID: 29521204
[TBL] [Abstract][Full Text] [Related]
6. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
7. Review on chemogenomics approach: interpreting antagonist activity of secreted frizzled-related protein 1 in glaucoma disease with in-silico docking.
Dave K; Panchal H
Curr Top Med Chem; 2012; 12(16):1834-42. PubMed ID: 23030617
[TBL] [Abstract][Full Text] [Related]
8. Protein-ligand-based pharmacophores: generation and utility assessment in computational ligand profiling.
Meslamani J; Li J; Sutter J; Stevens A; Bertrand HO; Rognan D
J Chem Inf Model; 2012 Apr; 52(4):943-55. PubMed ID: 22480372
[TBL] [Abstract][Full Text] [Related]
9. A Structural Framework for GPCR Chemogenomics: What's In a Residue Number?
Vass M; Kooistra AJ; Verhoeven S; Gloriam D; de Esch IJP; de Graaf C
Methods Mol Biol; 2018; 1705():73-113. PubMed ID: 29188559
[TBL] [Abstract][Full Text] [Related]
10. Chemogenomic approaches to rational drug design.
Rognan D
Br J Pharmacol; 2007 Sep; 152(1):38-52. PubMed ID: 17533416
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances in the System Biology-based Target Identification and Drug Discovery.
Yadav BS; Tripathi V
Curr Top Med Chem; 2018; 18(20):1737-1744. PubMed ID: 30360719
[TBL] [Abstract][Full Text] [Related]
12. Polypharmacological Drug-target Inference for Chemogenomics.
Schneider P; Schneider G
Mol Inform; 2018 Sep; 37(9-10):e1800050. PubMed ID: 29797496
[TBL] [Abstract][Full Text] [Related]
13. Chemogenomics approaches for receptor deorphanization and extensions of the chemogenomics concept to phenotypic space.
van der Horst E; Peironcely JE; van Westen GJ; van den Hoven OO; Galloway WR; Spring DR; Wegner JK; van Vlijmen HW; Ijzerman AP; Overington JP; Bender A
Curr Top Med Chem; 2011; 11(15):1964-77. PubMed ID: 21470175
[TBL] [Abstract][Full Text] [Related]
14. Structure-Based Approaches to Target Fishing and Ligand Profiling.
Rognan D
Mol Inform; 2010 Mar; 29(3):176-87. PubMed ID: 27462761
[TBL] [Abstract][Full Text] [Related]
15. Assay Related Target Similarity (ARTS) - chemogenomics approach for quantitative comparison of biological targets.
Bieler M; Heilker R; Köppen H; Schneider G
J Chem Inf Model; 2011 Aug; 51(8):1897-905. PubMed ID: 21761911
[TBL] [Abstract][Full Text] [Related]
16. Quantitative chemogenomics: machine-learning models of protein-ligand interaction.
Andersson CR; Gustafsson MG; Strömbergsson H
Curr Top Med Chem; 2011; 11(15):1978-93. PubMed ID: 21470169
[TBL] [Abstract][Full Text] [Related]
17. Can We Rely on Computational Predictions To Correctly Identify Ligand Binding Sites on Novel Protein Drug Targets? Assessment of Binding Site Prediction Methods and a Protocol for Validation of Predicted Binding Sites.
Broomhead NK; Soliman ME
Cell Biochem Biophys; 2017 Mar; 75(1):15-23. PubMed ID: 27796788
[TBL] [Abstract][Full Text] [Related]
18. Chemogenomics knowledge-based strategies in drug discovery.
Jacoby E; Schuffenhauer A; Floersheim P
Drug News Perspect; 2003 Mar; 16(2):93-102. PubMed ID: 12792670
[TBL] [Abstract][Full Text] [Related]
19. Active learning for computational chemogenomics.
Reker D; Schneider P; Schneider G; Brown JB
Future Med Chem; 2017 Mar; 9(4):381-402. PubMed ID: 28263088
[TBL] [Abstract][Full Text] [Related]
20. [Computational chemistry in structure-based drug design].
Cao R; Li W; Sun HZ; Zhou Y; Huang N
Yao Xue Xue Bao; 2013 Jul; 48(7):1041-52. PubMed ID: 24133970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
